The state of science in South Africa

Sixty-one years ago, South Africa's linkurl:Council for Scientific and Industrial Research;http://www.csir.co.za/plsql/ptl0002/ptl0002_pge001_home was established by a parliamentary decree that specifically required it to undertake research that improves the linkurl:wellbeing;http://www.the-scientist.com/news/display/23120/ of the country's people. Given this, I wasn't really surprised, on visiting CSIR's sprawling campus on the outskirts of the city of Pretoria, to find biosciences researchers

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Sixty-one years ago, South Africa's linkurl:Council for Scientific and Industrial Research;http://www.csir.co.za/plsql/ptl0002/ptl0002_pge001_home was established by a parliamentary decree that specifically required it to undertake research that improves the linkurl:wellbeing;http://www.the-scientist.com/news/display/23120/ of the country's people. Given this, I wasn't really surprised, on visiting CSIR's sprawling campus on the outskirts of the city of Pretoria, to find biosciences researchers focusing on issues to do with HIV, malaria, linkurl:tuberculosis;http://www.the-scientist.com/article/display/15477/ and improving nutrition. I dropped by the campus during my 10 day linkurl:trip to Africa;http://www.the-scientist.com/blog/display/23265/ on behalf of The Scientist to linkurl:survey;http://www.the-scientist.com/article/display/21567/ the region?s science. In the plant biotechnology group, for example, group leader Rachel Chikwamba showed me around one lab where investigators are using microarrays and proteomics to examine lead compounds from indigenous plants as potential antimalarials. Down the hall, she introduced me to investigators who have had some success in producing plants that express a rabies monoclonal antibody. In the greenhouses outside, her group is growing transgenic sorghum -- an African crop plant. In one project their aim is to develop sorghum lines with nutritional enhancements such as added vitamins, amino acids, iron or zinc. And elsewhere in the building, Makohetsa Khati told me that he is building on work he conducted at Oxford University to utilize aptamer technology for developing novel antiretrovirals and diagnostic tools for diseases like tuberculosis. As the CSIR's group manager for research and development, David Walwyn, told me this morning, South Africa's research strengths have long included the medical and biological sciences. Given some of the enormous health challenges facing the country today, this is at least something to be thankful for.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies